RICHLAND, Wash., May 10, 2017 /PRNewswire/ — IsoRay, Inc. (NYSE MKT: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications for the treatment of prostate, brain, lung, head and neck and gynecological cancers,…
May 10, 2017 at 05:21PM
from
No comments:
Post a Comment